Networking +
Policy +
Member
Career
Choose
Weekly Policy Update: CBSA Takes Positions on Additional Bills, Transparency News, and China Tariffs
By: Colorado BioScience Association Date: 04/13/2018
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week. With 18 working days left of session we continue to evaluate and make recommendations on legislation...
Learn MoreWeekly Policy Update: CO House Votes on Prescription Drug Price Transparency Bill Monday!
By: Colorado BioScience Association Date: 04/06/2018
Colorado House Votes next week on Prescription Drug Price Transparency Bill (HB18-1260) CBSA continues to advocate against House Bill 1260, Prescription Drug Price Transparency. The bill could stifle...
Learn MoreWeekly Policy Update: Colorado Budget and Forecast, plus a True Transparency update
By: Colorado BioScience Association Date: 03/30/2018
CO State Budget & March Forecast Transportation, Education, PERA, and opioid addiction are a few of the areas that will receive funding in the $28.9 billion state budget package passed by the Colo...
Learn MoreWeekly Policy Update: Advocacy Around Drug Transparency Issues, an Opportunity To Be Heard By the Next Governor, and the Omnibus Spending Bill
By: Colorado BioScience Association Date: 03/23/2018
This week CBSA testified in opposition to House Bill 1009, Diabetes Drug Pricing Transparency Act 2018. The bill was heard in the House Health, Insurance and Environment Committee and passed on a part...
Learn MoreWeekly Policy Update: Continuing the Transparency Advocacy and a Business Guide for the Governor
By: Colorado BioScience Association Date: 03/16/2018
CBSA Continues to Advocate in Opposition to House Bill 1260, Prescription Drug Price Transparency As reported last week, House Bill 1260, Prescription Drug Price Transparency passed on a party line vo...
Learn MoreWeekly Policy Update: Prescription Drug Price Transparency
By: Colorado BioScience Association Date: 03/09/2018
Transparency at the Colorado State Capitol This week CBSA testified in opposition to House Bill 1260, Prescription Drug Price Transparency. The bill was heard in the House Health, Insurance and Enviro...
Learn MoreWeekly Policy Update: House Bill 1260 Prescription Drug Transparency, plus the Advamed Fly-In in Washington, D.C.
By: Colorado BioScience Association Date: 03/02/2018
Urge a NO Vote on HB 1260, Prescription Drug Price Transparency This week CBSA opposed a new bill introduced by the Colorado House that could adversely impact the Colorado bioscience industry, Ho...
Learn MoreWeekly Policy Update: Positions on three bills, true transparency, and a visit to D.C.
By: Colorado BioScience Association Date: 02/23/2018
UNDER THE DOME The Colorado BioScience Association took formal positions on three bills this week and we continue to evaluate and make recommendations on legislation being introduced. Outlined below a...
Learn MoreWeekly Policy Update: True Transparency and Medicare Stakeholder Input
By: Colorado BioScience Association Date: 02/16/2018
CBSA promotes the interests of more than 725 bioscience companies and their 30,000 employees. We work every day to create an innovation-friendly business environment ensuring that as an industry we de...
Learn MoreWeekly Policy Update: Colorado BioScience Association Highlights State's Life-Saving Medical Breakthroughs for Lawmakers
By: Colorado BioScience Association Date: 02/09/2018
This week we had a successful CBSA Day at the Capitol. At the event we heard from Lieutenant Governor Donna Lynne on her top priorities, outlook on the opioid and substance abuse task force and the fu...
Learn More